secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dare Bioscience, Inc. (DARE)
CIK:        0001401914
Form:       8-K
Filed at:   2025-04-11T23:59:59+00:00
Accession:  0001641172-25-003887
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq grants Daré extension until Aug 12, 2025 to regain listing compliance
----------------------------------------------------------------------------

- Extension conditional on meeting stockholders' equity >$2.5M by April 30, 2025 and further increase by July 15, 2025.
- Company must publicly disclose equity-raising transactions and provide 12-month projections by August 12, 2025.
- Non-compliance with Nasdaq Rule 5550(b) since August 2024; risk of delisting if conditions not met.
- Panel may reconsider extension or delist after April 30 if plan execution falters.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401914/000164117225003887/0001641172-25-003887-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401914/000164117225003887/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-003887

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer